Previous Article | Next Article 
J Virol, August 1998, p. 6602-6607, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Involvement of Human CRM1 (Exportin 1) in the
Export and Multimerization of the Rex Protein of Human T-Cell
Leukemia Virus Type 1
Yoshiyuki
Hakata,1
Tomoe
Umemoto,1
Shuzo
Matsushita,2 and
Hisatoshi
Shida1,*
Institute for Virus Research, Kyoto
University, Kyoto 606,1 and
The Second
Department of Internal Medicine, Kumamoto University Medical School,
Kumamoto 860,2 Japan
Received 3 March 1998/Accepted 5 May 1998
 |
ABSTRACT |
We investigated the role of human CRM1 (hCRM1) (exportin 1) in the
function of Rex protein encoded by human T-cell leukemia virus type 1. hCRM1 promoted the export of Rex protein from the nucleus to the
cytoplasm. A Rex protein with a mutation in the activation domain,
RexM90, lost both the ability to bind to hCRM1 and the ability to
multimerize. The overexpression of hCRM1 complemented the functional
defects of RexM64, which contains a mutation in the multimerization
domain of Rex. A dominant-negative mutant of Rex which sequesters
cofactors of Rex abrogated multimerization as well as the activity of
the wild-type Rex protein. These two functions were simultaneously
restored by the overexpression of hCRM1. Taken together, these results
suggest that hCRM1 plays important roles in the multimerization and
export of Rex protein.
 |
INTRODUCTION |
The Rex protein of human T-cell
leukemia virus type 1 acts posttranscriptionally to induce the
cytoplasmic expression of incompletely spliced or unspliced mRNAs
encoding viral structural proteins (16, 18, 34). Although
the exact mechanism of action of Rex has not been elucidated, it is
generally accepted that Rex shuttles between the nucleus and the
cytoplasm (4, 20) in a process that involves the binding of
Rex to specific regions of viral RNAs and their subsequent escort into
the cytoplasm (1, 3, 14, 15, 32). Rex acts through
cis-acting elements, referred to as Rex response elements
(RXRE), within the 3' long terminal repeat of human T-cell leukemia
virus type 1 (32). Direct interaction between Rex and RXRE
has been shown by various in vitro binding assays, and this interaction
has turned out to be essential for their in vivo activity (1, 3,
14, 15). A discrete region in the amino terminus of the Rex
protein which is rich in basic amino acids has been shown to mediate
binding to RXRE (1, 3, 14). This region also works as a
nuclear and nucleolar targeting signal (NLS) (33). A second
essential region, in the carboxy-terminal portion of the Rex protein,
contains a leucine-rich activation domain which was shown to function
as a nuclear export signal (NES) by binding to cellular cofactors (4, 20). Human immunodeficiency virus (HIV) type 1 contains the regulatory protein Rev, which is functionally equivalent to Rex
(7, 8). Rev possesses two functional domains comparable to
those of Rex (6, 24-27, 41, 43).
Mutational analysis of Rev and Rex revealed a third domain responsible
for the multimerization of these transactivator proteins (2,
26). Multimerization is generally agreed to be critical for Rev
and Rex function (26). Although there has been some inconsistency in the mapping of the domain(s) involved in
multimerization, all studies have revealed the importance of the
N-terminal region of the Rev protein, comprising
tyrosine23, serine25, and
asparagine26 (2, 26, 37). The domain containing
amino acids near positions 60 to 70 of the Rex protein has been shown
to functionally replace the amino-terminal region of the Rev protein
(42). Interestingly, cellular cofactors have been proposed
to be involved in multimerization on the basis of the failure of Rev
activation domain mutants to oligomerize in two kinds of two-hybrid
assays in mammalian cells (2, 23). However, the involvement
of the activation domain of Rev in multimerization was contraindicated
by observations showing the mislocalization of wild-type Rev when
coexpressed with the activation domain mutants, a result that suggested
that heterooligomers had been formed (17, 36, 37). However,
the involvement of the Rex activation domain in multimerization has not
been extensively studied. To further pursue this subject, it seems
necessary to examine the nature of the cellular cofactor(s) directly.
Recently, human CRM1 (hCRM1) (exportin 1) was found to be a
receptor for various NES sequences, including the activation domain of
Rev. hCRM1 belongs to the importin
family, the members of which act
as carriers to transport proteins between the cytoplasm and the nucleus
(11, 13, 22, 28, 29, 35, 39). Recently, hCRM1 was shown to
form a complex with NES and GTP-loaded Ran, the predominant form found
in the nucleus, but not with NES in the presence of GDP-loaded Ran, the
predominant form found in the cytoplasm (11). Although these
studies clearly indicated that hCRM1 is a major cofactor functioning in
the export of Rev, they were done with experimental model systems, such
as yeast cells (13, 22, 28, 35), amphibian oocytes (11,
13), and artificially constructed reporter proteins containing
both NLS and NES (29). Thus, only a few of the functions
carried out by hCRM1 have been adequately addressed.
Dominant-negative (DN) mutants, which inhibit the function of
coexpressed wild-type Rev and Rex, have been very useful for investigating the molecular mechanisms underlying Rev and Rex function
(2, 19, 24, 27, 40). For example, the RevM10 mutant protein,
a prototype of a DN mutant, provided an important clue in the
identification of the activation domain (24, 40). More
recently, TAgRex, which has the NLS of simian virus 40 T antigen in
place of the normal RNA binding domain of the Rex protein, was
constructed (19). Since TAgRex inhibits Rev and Rex function by sequestering a cellular cofactor(s), it can be used to classify the
routes by which various mRNAs and proteins are exported from the
nucleus to the cytoplasm (10, 19, 21, 30, 31). TAgRex may
also supply a means to approve cellular cofactors of Rex, as such
factors would be expected to abrogate the DN effect of TagRex.
The present study was conducted to investigate the roles of hCRM1 in
Rex function by use of TAgRex in human cells. We show that hCRM1 is
involved in both the export and the multimerization of the Rex protein.
 |
MATERIALS AND METHODS |
Plasmid construction.
To construct pSR
hCRM1, the
hCRM1 gene containing the entire coding region was amplified from a
human placental cDNA library (Clontech Co. Ltd.) by the PCR technique
with primers 5'-GTTCAATCTCTGGTAATCTATGCCAGC-3' (CRMF1) and
5'-CCCAGCCACAAAAATGGGCATGAAG-3' (CRMR1). The PCR product was
gel purified and used as a template for a second PCR with primers
5'-AACGGTACCCGCACTAGTCACACATTTCTTCTGGAATCTCATGTGGAT-3' and
CRMF1. The second PCR product was blunt ended by Pfu
polymerase treatment, digested with KpnI, and cloned into
pSR
296 (38) which had been digested with PstI,
blunt ended with Pfu polymerase, and then digested with
KpnI. The resultant plasmid was named pSR
hCRM1. The
integrity of the plasmid sequence was ascertained by sequencing according to the manufacturer's instructions (Applied Biosystem Co.
Ltd.).
To generate pGAL-CRM1, the coding sequence of the CRM1 gene was
amplified by PCR with the primer pair
5'-GGAAGATCTTTCAATCTCTGGTTATCTATGCCAGC-3' and CRM2 and with
the first PCR product described above as a template. The PCR product
was treated with Pfu polymerase, digested with BglII, and cloned in frame downstream of the GAL4 DNA
binding domain sequence in pSGGALVP (12), which had been
digested with BamHI, blunt ended, and then digested with
BglII. To make pGAL4, pSGGALVP was digested with
BglII and BamHI and then self-ligated. To
construct pSR
RexM64, a 500-bp fragment generated by the digestion of
pSR
Rex with NcoI/AvrII and a fragment
encoding the C-terminal region of Rex derived from pSR
TAgRexM64
by digestion with NcoI/EcoRI were
ligated with pSR
296 that had been linearized with
AvrII/EcoRI. Plasmid pSR
RexM90 was constructed
in the same way, except that pSR
TAgRexM90 was used as the source of
the fragment encoding the C-terminal region of Rex. In this way,
pSR
RexM64 carried a protein containing amino acid substitutions of
Asp and Leu for Tyr-64 and Trp-65, respectively, and pSR
RexM90
carried a protein containing single Gly substitutions for Leu-90,
Ser-91, Leu-92, and Asp-93.
pSR
Rex, pSR
TAgRexM64, pSR
TAgRexM90, pSR
TAgRexM6490,
pCDM-
-gal, pGAL-Rex, pRex-VP, pGAL-RexM64, pRexM64-VP, pGAL-RexM90, pRexM90-VP, and pTU50RXE were described previously (19, 21).
Cell culture and transfection.
HeLa cells were maintained in
RPMI medium supplemented with 10% fetal calf serum in a 5%
CO2 atmosphere at 37°C. Plasmid DNA was transfected with
DOTAP (Boehringer Mannheim Co. Ltd.) according to the manufacturer's
instructions. In order to normalize for variations in transfection
efficiency and nonspecific effects of various treatments, 0.1 µg of
pCDM-
-gal was included in all samples and the total amount of DNA
was kept constant by adding pSR
296.
In vivo assay of protein-protein interactions.
The
two-hybrid system was used to analyze protein-protein interactions in
mammalian cells (12). HeLa cells were cotransfected with 0.2 µg of the plasmid that expresses the GAL fusion protein, 0.2 µg of
the plasmid that expresses the VP16 fusion protein, 0.6 µg of pG5BCAT
as a reporter, and 0.1 µg of pCDM-
-gal. Twenty-four hours after
transfection, the cells were harvested, the amount of chloramphenicol
acetyltransferase (CAT) and the activity of
-galactosidase were
quantified with a CAT enzyme-linked immunosorbent assay (ELISA) kit
(Boehringer) and standard colorimetric methods, respectively, and the
ratio of CAT to
-galactosidase was calculated.
Env ELISA.
HeLa cells were transfected with various amounts
of pSR
Rex or with a pSR
Rex mutant along with 0.5 µg of
pTU50RXRE as a reporter plasmid; the latter expresses the HIV type 1 Env protein in the presence of a functional Rex protein. The Env
protein was mutated to remove the transmembrane domain and was secreted
into the medium (21). Forty-eight hours after transfection,
the culture medium of each sample was transferred to a
microcentrifugation tube and centrifuged at a low speed. The cells
remaining on the bottom of a six-well plate were lysed with the lysis
buffer contained in the CAT ELISA kit. One-fifth of the supernatant was
added to a 96-well plate which had been coated with anti-Env monoclonal antibody 0.5
, and the plate was incubated at 37°C for 1 h.
The plate was washed five times with the washing buffer contained in
the CAT ELISA kit. Human anti-HIV antisera diluted 100-fold were added
to the wells of the plate, and the plate was incubated. Finally,
peroxidase-conjugated anti-human immunoglobulin G antibody was added.
The cell lysates were used to measure
-galactosidase activity, and
the ratio of Env to
-galactosidase was calculated.
Immunofluorescence.
HeLa cells were transfected with
pSR
Rex, pSR
RexM64, of pSR
RexM90 in the presence or absence of
pSR
hCRM1. Twenty-four h after transfection, the cells were fixed and
incubated with rabbit anti-Rex C terminus antibody, and the
immunocomplexes were stained with fluorescein isothiocyanate-conjugated
goat anti-rabbit immunoglobulin G antibody as previously described
(19).
Western blotting.
HeLa cells were transfected with 0.2 µg
of each plasmid DNA. Forty-eight hours later, the cells were lysed, and
the extracted proteins were separated on 10% polyacrylamide gels. The
proteins were then transferred to a nitrocellulose filter and incubated with rabbit anti-Rex C terminus-antibody followed by alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G antibody (19).
 |
RESULTS |
Promotion of nuclear export of the Rex protein by hCRM1.
In
order to study whether hCRM1 is involved in the nuclear export of the
Rex protein, the effect of overexpression of hCRM1 on the localization
of the Rex protein was examined by immunofluorescence microscopy. We
analyzed not only wild-type Rex but also RexM64, which has a mutation
in the multimerization domain, and RexM90, which has a mutation in the
activation domain (19). All of these Rex-related proteins
were found to be predominantly located in the nucleus and were
especially concentrated in the nucleolus, confirming previous reports
(33). However, when hCRM1 was overexpressed by transfection,
Rex and RexM64 tended to be localized in the cytoplasm, whereas the
location of RexM90 was not affected (Fig. 1). Quantitative evaluation confirmed the
above observations, but we noticed that hCRM1 enhanced the cytoplasmic
localization of wild-type Rex more efficiently than RexM64 (Table
1). This finding may be attributable to
the slightly reduced affinity of RexM64 compared to wild-type Rex for
hCRM1 (see Fig. 3) or the adverse effect of the mutation in the
multimerization domain. These results indicate that the intact
activation domain of Rex is required for hCRM1 to localize Rex to the
cytoplasm. The results are also consistent with previous reports
showing that hCRM1 exports various proteins possessing an NES sequence
(11, 13, 22, 28, 29, 35, 39).

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 1.
Subcellular localization of wild-type and mutant Rex
proteins. At 24 h after transfection, cells transfected with 0.1 µg of pSR Rex (A and D), pSR RexM64 (B and E), or pSR RexM90 (C
and F) in combination with 0.5 µg of pSR hCRM1 (D, E, and F) or 0.5 µg of pSR 296 instead of pSR hCRM1 in order to adjust the total
amounts of the plasmids (A, B, and C) were subjected to
immunofluorescence microscopy. Magnification, ×1,720.
|
|
Abrogation of the DN effect of TAgRex by hCRM1.
In previous
studies, we showed that TAgRex inhibits Rex function by sequestering
cellular cofactors and that the intact activation domain of TAgRex is
responsible for this inhibition (19, 21). This system may be
used to identify cellular cofactors that are involved in the
functioning of Rex through its activation domain, since overexpression
of these cofactors would be expected to abrogate the DN effect of
TAgRex (19). To explore the role of hCRM1 in Rex function,
we used this approach with some modifications, including the use of
pTU50RXRE as a reporter plasmid and TAgRexM64 as an inhibitor. These
modifications allowed quantification of the amount of Env protein
produced as a result of the action of Rex and straightforward interpretation, since TAgRexM64 does not form hetero-oligomers with Rex
(21). We reproduced our previous results (19,
21), showing that TAgRexM64 interferes with Rex function
efficiently: transfection of 0.1, 0.2, and 0.3 µg of pSR
TAgRexM64
reduced the production of Env protein to 37, <1, and <1%,
respectively, that normally observed in the absence of TAgRexM64 (data
not shown). Next, we examined the effect of the overexpression of hCRM1
on Rex function in the presence of TAgRexM64 (Fig.
2). Rex-dependent production of Env
protein was restored by the overexpression of hCRM1 in a dose-dependent
manner. Notably, the transfection of 0.5 µg of pSR
hCRM1 achieved
full restoration of Env production. On the other hand, the
overexpression of hCRM1 in the absence of TAgRexM64 did not affect Rex
function significantly, probably because the amount of intrinsic hCRM1
was sufficient to support Rex function. These results suggest that
hCRM1 is a major cofactor involved in Rex function.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
Overexpression of hCRM1 restores Rex activity inhibited
by TAgRexM64. HeLa cells were transfected with 0.05 µg of pSR Rex,
0.5 µg of pTU50RXRE as a reporter plasmid, and various amounts of
pSR hCRM1 with ( ) or without ( ) 0.2 µg of pSR TAgRexM64.
pCDM- -gal (0.1 µg) was included in all samples as an internal
control. At 48 h after transfection, the cells were harvested, the
amount of Env and the activity of -galactosidase were quantified,
and the ratios of Env to -galactosidase were calculated. The ratio
of the amounts of Env and -galactosidase obtained in the sample in
which TAgRexM64 and pSR hCRM1 were omitted was arbitrarily set at
1.
|
|
Interaction of hCRM1 with Rex proteins.
To obtain evidence for
an interaction between Rex and hCRM1, two-hybrid analysis was performed
with HeLa cells. In the two-hybrid experiments, we prepared cell
lysates 24 h after transfection to prevent the overaccumulation of
RexM90 in the nucleus. This step we hoped would reduce the deleterious
effects of RexM90 overexpression on cell functions, which are due to
the export defect of RexM90, which lacks an intact NES. Indeed, earlier
preparation of the samples ensured more reproducible results than did
preparation 48 h after transfection (data not shown) (2,
19). As shown in Fig. 3, wild-type
Rex and RexM64 interacted similarly with hCRM1. In contrast, RexM90 had
a greatly reduced affinity for hCRM1, suggesting that the intact
activation domain of Rex is required for efficient interaction with
hCRM1. Since it was difficult to produce a large amount of hCRM1
protein in Escherichia coli because of its instability, we
could not analyze the direct interaction of Rex and hCRM1 in an in
vitro protein-protein interaction assay.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 3.
Interaction of hCRM1 with Rex, RexM64, and RexM90
in the nuclei of mammalian cells. A mammalian version of the two-hybrid
assay with transient expression by transfection into HeLa cells was
performed. The hCRM1 protein was expressed as a GAL4 fusion, and the
other proteins were expressed as VP16 fusions. pCDM- -gal (0.1 µg)
was included in all samples as an internal control. At 24 h after
transfection, the cells were harvested, and the amount of CAT and the
activity of -galactosidase were quantified. The amount of CAT and
the activity of -galactosidase obtained after transfection of Rex-VP
and GAL-hCRM1 were 370 pg and 2.5 × 10 3 U,
respectively, and the ratio (CAT/ -galactosidase) was arbitrarily set
at 1. GAL4 represents the plasmid expressing only the GAL4 region.
|
|
Rex mutants fail to multimerize.
Although the above results
are consistent with reports describing hCRM1 as an NES receptor
(11, 13, 22, 28, 29, 35, 39), the residual ability of RexM90
(approximately 20% that of wild-type Rex) to interact with hCRM1 was
unexpected. Thus, we examined whether RexM90 retained the residual
activity to produce Env protein compared to wild-type Rex and RexM64,
since quantitative analysis was possible with pTU50RXRE as a reporter. As shown in Fig. 4, RexM90 showed very
low activity (approximately 3% that of wild-type Rex at most) and
RexM64 had virtually no activity at all.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Activities of Rex, RexM64, and RexM90. Cells were
transfected with 0.5 µg of pTU50RXRE and increasing quantities of
pSR Rex ( ), pSR RexM64 ( ), or pSR RexM90 ( ). The culture
medium was harvested at 48 h posttransfection, the amount of Env
protein produced was assayed, and the cell lysates were used for the
quantification of -galactosidase expression levels. The
Env/ -galactosidase ratio for each sample was divided by that for the
sample without Rex and expressed as fold activation.
|
|
The low activity of RexM90 appeared to be inconsistent with its ability
to interact with hCRM1. In order to explore the cause
of the low
activity of RexM90, we reanalyzed the capacity of Rex-related
proteins
to multimerize. As depicted in Fig.
5,
only the combination
of GAL-Rex with Rex-VP showed significant
multimerization. No
other combination, including Rex-RexM64,
RexM64-RexM64, Rex-RexM90,
and RexM90-RexM90, resulted in the formation
of hetero- or homo-oligomers.
It was ascertained by Western blotting
that all of the fusion
proteins were correctly synthesized and were
present in a stable
form in the transfected cells (Fig.
6). These results are in accord
with the
results reported by Bogerd and Greene (
2). Thus, the
multimerization defect of RexM90 may account for its very weak
capacity
to induce Env production.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 5.
Analysis of in vivo multimerization of the wild-type and
mutant Rex proteins. HeLa cells were cotransfected with the expression
plasmids for GAL and VP16 fusion proteins as indicated. The cells were
harvested 24 h after transfection, and the amount of CAT and the
activity of -galactosidase were quantified. The amount of CAT and
the activity of -galactosidase resulting from the coexpression of
GAL-Rex and Rex-VP were 270 pg and 4.8 × 10 3 U,
respectively, and the ratio was assigned a value of 1.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 6.
Western blot analysis of GAL-Rex and Rex-VP fusion
protein expression in HeLa cells. The results for the control (lane 1)
and for RexM90-VP (lane 2), RexM64-VP (lane 3), Rex-VP (lane 4),
GAL-RexM90 (lane 5), GAL-RexM64 (lane 6), and GAL-Rex (lane 7) are
shown.
|
|
Restoration of Rex multimerization by the overexpression of
hCRM1.
The above results raise the possibility that a cofactor may
be involved in the multimerization of the Rex protein. If so, the
activity of RexM64, which has a mutation in the multimerization domain,
may be complemented by the overexpression of hCRM1. We tested this
possibility by cotransfecting pSR
hCRM1 along with a wild-type Rex-
or mutant Rex-expressing plasmid. As shown in Table
2, the overexpression of hCRM1 restored
the activity of RexM64 up to one third that of wild-type Rex in a
dose-dependent manner, whereas it had a little effect on RexM90. These
results are consistent with the observation that RexM64 can associate with hCRM1 more efficiently than RexM90 (Fig. 3).
We examined the ability of wild-type and mutant Rex proteins to
multimerize under conditions of hCRM1 overexpression (Table
3). The overexpression of hCRM1 allowed
RexM64 to multimerize,
albeit at a level that was still inefficient
compared to that
of wild-type Rex. In contrast, it did not affect the
ability of
RexM90 to multimerize. The simultaneous restoration of
RexM64
activity and multimerization by overexpression of hCRM1 supports
the hypothesis that hCRM1 is involved in the multimerization of
the Rex
protein and that this process is a prerequisite for its
biological
activity.
Effect of a DN mutant and hCRM1 on the multimerization of wild-type
Rex.
If hCRM1 is involved in the multimerization not only of
mutant Rex but also of wild-type Rex, it is conceivable that TAgRexM64 may abrogate the multimerization of wild-type Rex in spite of the
inability of RexM64 and Rex to form hetero-oligomers (Fig. 5). We
tested this possibility by cotransfecting pSR
TAgRexM64 in the
two-hybrid assay. As a negative control, we used TAgRexM6490, which
lacks both intact multimerization and intact activation domains
(19). Figure 7 shows that the
multimerization of Rex was severely inhibited by the coexpression of
TAgRexM64, in contrast to the marginal effect of TAgRexM6490. These
results suggest that overexpression of the intact activation domain may
be required for the inhibition of multimerization, implying an
involvement of hCRM1 in multimerization.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 7.
Inhibitory effect of TAgRexM64 and TAgRexM6490 on
Rex-Rex multimerization. HeLa cell cultures were transfected with
pGAL-Rex and pRex-VP in combination with various amounts of
pSR TAgRexM64 ( ) or with pSR TAgRexM6490 ( ). At 24 h
posttransfection, the cells were harvested, and the amount of CAT and
the activity of -galactosidase were quantified. The amount of CAT
and the activity of -galactosidase obtained with transfection of
pRex-VP and pGAL-Rex without any TAgRex expression plasmid were 230 pg
and 4.5 × 10 3 U, respectively, and the ratio was
arbitrarily set at 1.
|
|
Next, we examined whether or not the overexpression of hCRM1
suppresses the inhibitory effect of TAgRexM64 on multimerization.
As
shown in Fig.
8, the extent of
multimerization of Rex gradually
increased with the amount of
pSR

hCRM1 cotransfected into cells.
These results suggest that hCRM1
may be required for the multimerization
of wild-type Rex protein.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 8.
Overexpression of hCRM1 restores Rex-Rex multimerization
inhibited by TAgRexM64. HeLa cell cultures were transfected with
pGAL-Rex, pRex-VP, and 0.2 µg of pSR TAgRexM64 in combination with
various amounts of pSR hCRM1. The amount of CAT and the activity of
-galactosidase obtained with transfection of pRex-VP and pGAL-Rex
without pSR TAgRexM64 were 380 pg and 6.8 × 10 3
U, respectively, and the ratio was arbitrarily set at 1.
|
|
 |
DISCUSSION |
In this paper we describe two roles for hCRM1 in Rex
function. First, hCRM1 facilitates the export of the Rex protein from the nucleus to the cytoplasm, since the overexpression of hCRM1 localized the Rex protein to the cytoplasm. This effect required the
intact activation domain of the Rex protein, since RexM90, which has a
mutation in the activation domain, remained in the nucleus. Also, the
ability of Rex-related proteins to localize to the cytoplasm was
dependent on their association with hCRM1. Furthermore, the
overexpression of hCRM1 fully restored the function of Rex inhibited
trans dominantly by TAgRexM64, suggesting that hCRM1 is a
major cofactor for Rex. Since Rev and Rex have been shown to share the
same route for the transport of their cognate mRNAs (19),
these results are consistent with hCRM1 being an NES receptor for the
export of shuttling proteins, including Rev (11, 13, 22, 29,
35).
Our previous report suggested that the translation initiation factor
eIF-5A abrogates the inhibitory effect of TAgRex on Rex function in
Cos7 cells (19). In recent experiments, however, we found
that the physiological condition of Cos7 cells greatly influences the
effect of eIF-5A, and we could not reproduce the effect in HeLa cells.
Thus, more extensive study will be required to discover the role of
eIF-5A in Rex function.
The second role for hCRM1 in the multimerization of the Rex protein was
shown by three experimental lines of evidence. First, RexM90 could not
multimerize, suggesting a role for the activation domain in
multimerization. Second, the activity of RexM64, which has a mutation
in the multimerization domain, was partially restored by the
overexpression of hCRM1, and this effect coincided with the partial
restoration of multimerization. Third, TAgRexM64 abrogated the ability
of the wild-type Rex protein to oligomerize, a defect that could be
corrected by furnishing exogenous hCRM1.
We used a two-hybrid assay to measure the ability to oligomerize. The
use of this assay to study Rev protein function has been criticized on
the basis of the abnormally high accumulation in the nucleus and
nucleolus of activation domain mutant proteins, which impair cellular
functions and lead to reduced CAT production (37). However,
we always cotransfected a plasmid expressing
-galactosidase as a
standard for normalization. Accordingly, the nonspecific impairment of
cellular function by RexM90 could not account for the reduction in CAT
production. In addition, the fact that RexM14, which has a mutation in
the activation domain, did not dominantly inhibit wild-type Rex
function in terms of RXRE-dependent gene expression (5), a
situation that differs from the DN phenotype of the Rev activation
domain mutants, suggested that a normal cellular environment existed
during the overexpression of the Rex activation domain mutant.
Oligomerization has been proposed to position individual
activation domains to create a domain sufficient for interaction with
the cellular cofactor (2, 23), namely, hCRM1. In this study,
we demonstrated that high concentrations of hCRM1 instead complement
the poor multimerization ability of Rex mutants and that even the
wild-type Rex protein requires a sufficient amount of hCRM1 to
multimerize. Thus, the intrinsic capability of Rex proteins to
multimerize may be necessary but not sufficient for multimerization in
vivo. Moreover, these results suggest that the multimerization of Rex
proteins is not a prerequisite for their interaction with hCRM1. For
these reasons, we propose that a Rex protein initially interacts with
an hCRM1 molecule, leading to the multimerization of Rex proteins in a
step that is favored by the intrinsic capacity of Rex proteins to
oligomerize. This process in turn would favor the formation of a more
favorable structure for interaction with supplementary hCRM1 molecules. We could not demonstrate homo-oligomerization of hCRM1 because a domain
of VP16 inactivated this function of hCRM1. However, Ran has been
reported to multimerize (9), suggesting the formation of a
large trimeric complex including hCRM1, Ran, and Rex. Alternatively, the binding of hCRM1 may induce conformational changes in Rex proteins,
leading to more efficient multimerization. Although we did not address
the role of RNA in this study, RNA could conceivably take part in the
multimerization process, as suggested previously (23, 26).
 |
ACKNOWLEDGMENTS |
We thank Y. Okuda for technical assistance.
This investigation was supported by grants from the Ministry of
Education, Science and Culture, Japan, and the Ministry of Health and
Welfare, Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute for
Virus Research, Kyoto University, Kyoto 606, Japan. Phone:
81-75-751-4016. Fax: 81-75-761-5626. E-mail:
hshida{at}virus.kyoto-u.ac.jp.
 |
REFERENCES |
| 1.
|
Ballaun, C.,
G. K. Farrington,
M. Dobrovnik,
J. Rusche,
J. Hauber, and E. Böhnlein.
1991.
Functional analysis of human T-cell leukemia virus type 1 Rex response element: direct RNA binding of Rex protein correlates with in vivo activity.
J. Virol.
65:4408-4413[Abstract/Free Full Text].
|
| 2.
|
Bogerd, H., and W. C. Greene.
1993.
Dominant negative mutants of human T-cell leukemia virus type 1 Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.
J. Virol.
67:2496-2502[Abstract/Free Full Text].
|
| 3.
|
Bogerd, H. P.,
G. L. Huckaby,
Y. F. Ahmed,
S. M. Hanly, and W. C. Greene.
1991.
The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements.
Proc. Natl. Acad. Sci. USA
88:5704-5708[Abstract/Free Full Text].
|
| 4.
|
Bogerd, H. P.,
R. A. Fridell,
R. E. Benson,
H. Jian, and B. R. Cullen.
1996.
Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay.
Mol. Cell. Biol.
16:4207-4214[Abstract].
|
| 5.
|
Böhnlein, S.,
F. P. Pirker,
L. Hofer,
K. Zimmermann,
H. Bachmayer,
E. Böhnlein, and J. Hauber.
1991.
Transdominant repressors for human T-cell leukemia virus type 1 Rex and human immunodeficiency virus type 1 Rev function.
J. Virol.
65:81-88[Abstract/Free Full Text].
|
| 6.
|
Cochrane, A. W.,
A. Perkins, and C. A. Rosen.
1990.
Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function.
J. Virol.
64:881-885[Abstract/Free Full Text].
|
| 7.
|
Cullen, B. R.
1991.
Regulation of human immunodeficiency virus replication.
Annu. Rev. Microbiol.
45:219-250[Medline].
|
| 8.
|
Cullen, B. R., and M. H. Malim.
1991.
The HIV-1 Rev protein: prototype of a novel class of eukaryotic post-transcriptional regulators.
Trends Biochem. Sci.
16:346-350[Medline].
|
| 9.
|
Dingwall, C.,
S. Kandel-Lewis, and B. Seraphin.
1995.
A family of Ran binding proteins that includes nucleoporins.
Proc. Natl. Acad. Sci. USA
92:7525-7529[Abstract/Free Full Text].
|
| 10.
|
Dobbelstein, M.,
J. Roth,
W. T. Kimberly,
A. J. Levine, and T. Shenk.
1997.
Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a Rev-like signal sequence.
EMBO J.
16:4276-4284[Medline].
|
| 11.
|
Fornerod, M.,
M. Ohno,
M. Yoshida, and I. W. Mattaj.
1997.
CRM1 is an export receptor for leucine-rich nuclear export signals.
Cell
19:1051-1060.
|
| 12.
|
Fujii, M.,
H. Tsuchiya,
T. Chuhjo,
T. Akizawa, and M. Seiki.
1992.
Interaction of HTLV-I Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes.
Genes Dev.
6:2066-2076[Abstract/Free Full Text].
|
| 13.
|
Fukuda, M.,
S. Asano,
T. Nakamura,
M. Adachi,
M. Yoshida,
M. Yanagida, and E. Nishida.
1997.
CRM1 is responsible for intracellular transport mediated by the nuclear export signal.
Nature
20:308-311.
|
| 14.
|
Grassman, R.,
S. Berchtold,
C. Aepinus,
C. Ballaun,
E. Boehnlein, and B. Fleckenstein.
1991.
In vitro binding of human T-cell leukemia virus Rex proteins to the Rex response element of viral transcripts.
J. Virol.
65:3721-3727[Abstract/Free Full Text].
|
| 15.
|
Hanly, S. M.,
L. T. Rimsky,
M. H. Malim,
J. J. Kim,
J. Hauber,
M. DucDodon,
S.-Y. Le,
J. V. Maizel,
B. R. Cullen, and W. C. Greene.
1989.
Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements.
Genes Dev.
3:1534-1544[Abstract/Free Full Text].
|
| 16.
|
Hidaka, M.,
J. Inoue,
M. Yoshida, and M. Seiki.
1988.
Post-transcriptional regulator (Rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins.
EMBO J.
7:519-523[Medline].
|
| 17.
|
Hope, T. J.,
N. P. Klein,
M. E. Elder, and T. G. Parslow.
1992.
trans-Dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes.
J. Virol.
66:1849-1855[Abstract/Free Full Text].
|
| 18.
|
Inoue, J.-I.,
M. Yoshida, and M. Seiki.
1987.
Transcriptional (p40×) and post-transcriptional (p27×-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes.
Proc. Natl. Acad. Sci. USA
84:3653-3657[Abstract/Free Full Text].
|
| 19.
|
Katahira, J.,
T. Ishizaki,
H. Sakai,
A. Adachi,
K. Yamamoto, and H. Shida.
1995.
Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type 1 Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.
J. Virol.
69:3125-3133[Abstract].
|
| 20.
|
Kim, F. J.,
A. A. Beeche,
J. J. Hunter,
D. J. Chin, and T. J. Hope.
1996.
Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions.
Mol. Cell. Biol.
16:5147-5155[Abstract].
|
| 21.
|
Kiyokawa, T.,
T. Umemoto,
Y. Watanabe,
S. Matsushita, and H. Shida.
1997.
Two distinct pathways for intronless mRNA expression: one related, the other unrelated to human immunodeficiency virus Rev and human T cell leukemia virus type I Rex functions.
Biol. Signals
6:134-142[Medline].
|
| 22.
|
Kudo, N.,
S. Khochbin,
K. Nishi,
K. Kitano,
M. Yanagida,
M. Yoshida, and S. Horinouchi.
1997.
Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins.
J. Biol. Chem.
21:29742-29751.
|
| 23.
|
Madore, S. J.,
L. S. Tiley,
M. H. Malim, and B. R. Cullen.
1994.
Sequence requirements for Rev multimerization in vivo.
Virology
202:186-194[Medline].
|
| 24.
|
Malim, M. H.,
S. Böhnlein,
J. Hauber, and B. R. Cullen.
1989.
Functional dissection of the HIV-1 Rev trans-activator deriviation of a trans-dominant repressor of Rev function.
Cell
58:205-214[Medline].
|
| 25.
|
Malim, M. H.,
L. S. Tiley,
D. F. McCarn,
J. R. Rusche,
J. Hauber, and B. R. Cullen.
1990.
HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.
Cell
60:675-683[Medline].
|
| 26.
|
Malim, M. H., and B. R. Cullen.
1991.
HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.
Cell
65:241-248[Medline].
|
| 27.
|
Malim, M. H.,
D. F. McCarn,
L. S. Tiley, and B. R. Cullen.
1991.
Mutational definition of the human immunodeficiency virus type 1 Rev activation domain.
J. Virol.
65:4248-4254[Abstract/Free Full Text].
|
| 28.
|
Neville, M.,
F. Stutz,
L. Lee,
L. Davis, and M. Rosbash.
1997.
The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export.
Curr. Biol.
7:767-775[Medline].
|
| 29.
|
Ossareh-Nazari, B.,
F. Bachelerie, and C. Dargemont.
1997.
Evidence for a role of CRM1 in signal-mediated nuclear protein export.
Science
278:141-144[Abstract/Free Full Text].
|
| 30.
|
Roth, J., and M. Dobbelstein.
1997.
Export of hepatitis B virus RNA on a Rev-like pathway inhibition by the regenerating liver inhibitory factor IkappaB alpha.
J. Virol.
71:8933-8939[Abstract].
|
| 31.
|
Roth, J.,
M. Dobbelstein,
D. A. Freedman,
T. Shenk, and A. J. Levine.
1998.
Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.
EMBO J.
17:554-564[Medline].
|
| 32.
|
Seiki, M.,
J.-I. Inoue,
M. Hidaka, and M. Yoshida.
1988.
Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I.
Proc. Natl. Acad. Sci. USA
85:7124-7128[Abstract/Free Full Text].
|
| 33.
|
Siomi, H.,
H. Shida,
S. H. Nam,
T. Nosaka,
M. Maki, and M. Hatanaka.
1988.
Sequence requirements for nucleolar localization of human T-cell leukemia virus type I pX protein, which regulates viral RNA processing.
Cell
55:197-209[Medline].
|
| 34.
|
Solomin, L.,
B. K. Felber, and G. N. Pavlakis.
1990.
Different sites of interaction for Rev, Tev, and Rex proteins within the Rev responsive element of human immunodeficiency virus type 1.
J. Virol.
64:6010-6017[Abstract/Free Full Text].
|
| 35.
|
Stade, K.,
C. S. Ford,
C. Guthrie, and K. Weis.
1997.
Exportin 1 (Crm1p) is an essential nuclear export factor.
Cell
90:1041-1050[Medline].
|
| 36.
|
Stauber, R.,
G. A. Gaitanaris, and G. N. Pavlakis.
1995.
Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm.
Virology
213:439-449[Medline].
|
| 37.
|
Szilvay, A. M.,
K. A. Brokstad,
S. O. Boe,
G. Haukenes, and K. H. Kalland.
1997.
Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import.
Virology
235:73-81[Medline].
|
| 38.
|
Takebe, Y.,
M. Seiki,
J. Fujisawa,
P. Hoy,
K. Yokota,
K. Arai,
M. Yoshida, and N. Arai.
1988.
SR promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.
Mol. Cell. Biol.
8:466-472[Abstract/Free Full Text].
|
| 39.
|
Ullman, K. S.,
M. A. Powers, and D. J. Forbes.
1997.
Nuclear export receptors: from importin to exportin.
Cell
90:967-970[Medline].
|
| 40.
|
Venkatesh, L. K., and G. Chinnadurai.
1990.
Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype.
Virology
178:327-330[Medline].
|
| 41.
|
Weichselbraun, I.,
G. K. Farrington,
J. R. Rusche,
E. Böhnlein, and J. Hauber.
1992.
Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type 1 Rex protein activation domain by functional exchange.
J. Virol.
66:2583-2587[Abstract/Free Full Text].
|
| 42.
|
Weichselbraun, I.,
J. Borger,
M. Dobrovnik,
H. Bogerd,
R. Grassmann,
W. C. Greene,
J. Hauber, and E. Böhnlein.
1992.
Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type 1 Rex protein: implications for trans dominance.
J. Virol.
66:4540-4545[Abstract/Free Full Text].
|
| 43.
|
Zapp, M. L., and M. R. Green.
1989.
Sequence-specific RNA binding by the HIV-1 Rev protein.
Nature (London)
342:714-716[Medline].
|
J Virol, August 1998, p. 6602-6607, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Takayanagi, R., Ohashi, T., Yamashita, E., Kurosaki, Y., Tanaka, K., Hakata, Y., Komoda, Y., Ikeda, S., Tsunetsugu-Yokota, Y., Tanaka, Y., Shida, H.
(2007). Enhanced Replication of Human T-Cell Leukemia Virus Type 1 in T Cells from Transgenic Rats Expressing Human CRM1 That Is Regulated in a Natural Manner. J. Virol.
81: 5908-5918
[Abstract]
[Full Text]
-
Sinha-Datta, U., Datta, A., Ghorbel, S., Dodon, M. D., Nicot, C.
(2007). Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication. J. Biol. Chem.
282: 14608-14615
[Abstract]
[Full Text]
-
Ariumi, Y., Trono, D.
(2006). Ataxia-Telangiectasia-Mutated (ATM) Protein Can Enhance Human Immunodeficiency Virus Type 1 Replication by Stimulating Rev Function. J. Virol.
80: 2445-2452
[Abstract]
[Full Text]
-
Choi, E.-A, Hope, T. J.
(2005). Mutational Analysis of Bovine Leukemia Virus Rex: Identification of a Dominant-Negative Inhibitor. J. Virol.
79: 7172-7181
[Abstract]
[Full Text]
-
Sandri-Goldin, R. M.
(2004). Viral Regulation of mRNA Export. J. Virol.
78: 4389-4396
[Full Text]
-
Hakata, Y., Yamada, M., Shida, H.
(2003). A Multifunctional Domain in Human CRM1 (Exportin 1) Mediates RanBP3 Binding and Multimerization of Human T-Cell Leukemia Virus Type 1 Rex Protein. Mol. Cell. Biol.
23: 8751-8761
[Abstract]
[Full Text]
-
Narayan, M., Younis, I., D'Agostino, D. M., Green, P. L.
(2003). Functional Domain Structure of Human T-Cell Leukemia Virus Type 2 Rex. J. Virol.
77: 12829-12840
[Abstract]
[Full Text]
-
Hakata, Y., Yamada, M., Mabuchi, N., Shida, H.
(2002). The Carboxy-Terminal Region of the Human Immunodeficiency Virus Type 1 Protein Rev Has Multiple Roles in Mediating CRM1-Related Rev Functions. J. Virol.
76: 8079-8089
[Abstract]
[Full Text]
-
Hakata, Y., Yamada, M., Shida, H.
(2001). Rat CRM1 Is Responsible for the Poor Activity of Human T-Cell Leukemia Virus Type 1 Rex Protein in Rat Cells. J. Virol.
75: 11515-11525
[Abstract]
[Full Text]
-
Narayan, M., Kusuhara, K., Green, P. L.
(2001). Phosphorylation of Two Serine Residues Regulates Human T-Cell Leukemia Virus Type 2 Rex Function. J. Virol.
75: 8440-8448
[Abstract]
[Full Text]
-
Neumann, M, Afonina, E, Ceccherini-Silberstein, F, Schlicht, S, Erfle, V, Pavlakis, G., Brack-Werner, R
(2001). Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein. J. Cell Sci.
114: 1717-1729
[Abstract]
-
Bogerd, H. P., Wiegand, H. L., Yang, J., Cullen, B. R.
(2000). Mutational Definition of Functional Domains within the Rev Homolog Encoded by Human Endogenous Retrovirus K. J. Virol.
74: 9353-9361
[Abstract]
[Full Text]
-
Magin, C., Lower, R., Lower, J.
(1999). cORF and RcRE, the Rev/Rex and RRE/RxRE Homologues of the Human Endogenous Retrovirus Family HTDV/HERV-K. J. Virol.
73: 9496-9507
[Abstract]
[Full Text]
-
Bodendorf, U., Cziepluch, C., Jauniaux, J.-C., Rommelaere, J., Salomé, N.
(1999). Nuclear Export Factor CRM1 Interacts with Nonstructural Proteins NS2 from Parvovirus Minute Virus of Mice. J. Virol.
73: 7769-7779
[Abstract]
[Full Text]
-
Weil, R., Levraud, J.-P., Dodon, M. D., Bessia, C., Hazan, U., Kourilsky, P., Israël, A.
(1999). Altered Expression of Tyrosine Kinases of the Src and Syk Families in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines. J. Virol.
73: 3709-3717
[Abstract]
[Full Text]
-
Stutz, F., Rosbash, M.
(1998). Nuclear RNA export. Genes Dev.
12: 3303-3319
[Full Text]